UCP2 and metabolic dysfunction-associated steatotic liver disease: NAFLD progression is amplified by inhibition of CPT-1, diminished mitochondrial FAO, and continuing ATP depletion, which is promoted by increased hepatic expression of uncoupling protein-2 (UCP2) [102].